U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2020
691
Name Type Language
NAXITAMAB
USAN   INN  
Official Name English
HU3F8
Preferred Name English
HUMANIZED 3F8
Common Name English
ANTI-GD2 MONOCLONAL ANTIBODY 3F8 HUMANIZED
Common Name English
NAXITAMAB [USAN]
Common Name English
HUMANIZED MONOCLONAL ANTIBODY HU3F8-IGG1
Common Name English
MONOCLONAL ANTIBODY HU3F8
Common Name English
naxitamab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMANIZED MUS MUSCULUS CLONE HU3F8 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MUS MUSCULUS CLONE HU3F8 LIGHT-CHAIN, DIMER
Systematic Name English
ANTI-GD2 IGG3 MONOCLONAL ANTIBODY 3F8 HUMANIZED
Common Name English
Naxitamab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS BETA-1,4 N-ACETYLGALACTOSAMINYLTRANSFERASE 1 ((N-ACETYLNEURAMINYL)-GALACTOSYLGLUCOSYLCERAMIDE, GM2/GD2 SYNTHASE))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (MUS MUSCULUS VH (IGHV2-9*02 (79%
Systematic Name English
HUMANIZED ANTI-GD2 MONOCLONAL ANTIBODY 3F8
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 416313
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
NCI_THESAURUS C20401
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
EU-Orphan Drug EU/3/18/2094
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
FDA ORPHAN DRUG 399613
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
Code System Code Type Description
CAS
1879925-92-4
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
PRIMARY
INN
10918
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
PRIMARY
DAILYMED
9K8GNJ2874
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
PRIMARY
EVMPD
SUB192785
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
PRIMARY
RXCUI
2474039
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
PRIMARY
NCI_THESAURUS
C123428
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
PRIMARY
SMS_ID
100000177409
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
PRIMARY
FDA UNII
9K8GNJ2874
Created by admin on Wed Apr 02 08:58:31 GMT 2025 , Edited by admin on Wed Apr 02 08:58:31 GMT 2025
PRIMARY
ACTIVE MOIETY
NAXITAMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966